Synthesis and structure–activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity-Reference-Cited by-同舟云学术

Synthesis and structure–activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity

Published:2008-12 Issue:23 Volume:16 Page:9911-9924
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Morini Giovanni,Comini Mara,Rivara Mirko,Rivara Silvia,Bordi Fabrizio,Plazzi Pier Vincenzo,Flammini Lisa,Saccani Francesca,Bertoni Simona,Ballabeni Vigilio,Barocelli Elisabetta,Mor Marco

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference60 articles.

1. Histamine and its receptors

2. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

3. Histamine H3 receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes

4. Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors

5. Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H₃ Receptors and Cholinesterases;ACS Chemical Neuroscience;2024-03-05

2. Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer’s disease;Bioorganic Chemistry;2021-09

3. Histamine H 3 receptor and cholinesterases as synergistic targets for cognitive decline: strategies to the rational design of multitarget ligands;Chemical Biology & Drug Design;2021-05-15

4. In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer’s disease;Computational Biology and Chemistry;2020-10

5. Multifunctional Ligands Targeting Phosphodiesterase as the Future Strategy for the Symptomatic and Disease-Modifying Treatment of Alzheimer’s Disease;Current Medicinal Chemistry;2020-09-25